Table 2. Duration of fever symptom in RDNI and oseltamivir groups.
| Influenza-infected participants | All treated paticipants | |||
|---|---|---|---|---|
| RDNI (n = 110) | Oseltamivir (n = 109) | RDNI (n = 118) | Oseltamivir (n = 118) | |
| Fever clearance time, P50(P25˜P75), h※ |
27 (25˜28) | 47 (45˜48) | 27 (25.5˜28.5) | 47 (45˜48) |
| HR, (95%CI)/P | 0.477 (0.362˜0.628)/<0.0001※ | 0.479 (0.367˜0.626)/<0.000# | ||
| Fever alleviation time, P50(P25˜P75), h※ | 2 (1.5˜2) | 6 (/˜/) | 2 (1.5˜2) | 6 (/˜/) |
| HR, (95%CI)/P | 0.345 (0.258˜0.460)/< 0.0001# | 0.335 (0.254˜0.443)/< 0.0001# | ||
※P50 indicates the median time. P25 and P75 indicate lower quartile and upper quartile. #HR< 1, and P < 0.0001 indicates that fever alleviation and clearance time are less in RDNI than in Oseltamivir, and with statistical differences.